Literature DB >> 2845117

Analysis of mutant Moloney murine leukemia viruses containing linker insertion mutations in the 3' region of pol.

L A Donehower1.   

Abstract

Twelve linker insertion mutations have been constructed in the 3' part of the pol gene of Moloney murine leukemia virus. This region of the Moloney murine leukemia virus genome encodes IN or p46pol, which is required for integration of the retroviral DNA into the host cell chromosome. Viral proteins synthesized by these mutants were used to pseudotype a neo-containing retroviral vector. Ten of twelve linker insertion mutant pseudotypes were unable to generate stable proviruses in infected mouse cells, as measured by the formation of G418-resistant colonies. Two mutants mapping at the 3' terminus of the IN-encoding region were competent for the formation of stable vector proviruses (hundreds of G418-resistant colonies per mutant pseudotype-infected plate). Representative linker insertion mutants were also tested for the ability to synthesize viral unintegrated DNA in newly infected cells. All assayed mutants were capable of synthesizing all normal forms of viral unintegrated DNA. The structure of integrated vector proviruses generated by defective and nondefective linker insertion mutants was also analyzed. All replication-competent mutants generated normal proviruses, while the few obtainable proviruses generated by replication-defective mutants were sometimes aberrant in structure. These results argue strongly (and confirm previous data) that the IN-encoding region of pol does not play a significant role in DNA synthesis, but is absolutely required for the formation of normal proviral DNA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2845117      PMCID: PMC253822     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  A 32,000-dalton nucleic acid-binding protein from avian retravirus cores possesses DNA endonuclease activity.

Authors:  D P Grandgenett; A C Vora; R D Schiff
Journal:  Virology       Date:  1978-08       Impact factor: 3.616

2.  Domain structure of the Moloney murine leukemia virus reverse transcriptase: mutational analysis and separate expression of the DNA polymerase and RNase H activities.

Authors:  N Tanese; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

3.  A C-terminal domain in the avian sarcoma-leukosis virus pol gene product is not essential for viral replication.

Authors:  R A Katz; A M Skalka
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

4.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

Review 5.  Zinc fingers: gilt by association.

Authors:  R M Evans; S M Hollenberg
Journal:  Cell       Date:  1988-01-15       Impact factor: 41.582

6.  A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins.

Authors:  S Crawford; S P Goff
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

7.  Studies on reverse transcriptase of RNA tumor viruses III. Properties of purified Moloney murine leukemia virus DNA polymerase and associated RNase H.

Authors:  I M Verma
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

8.  Purification and characterization of the DNA polymerase and RNase H activities in Moloney murine sarcoma-leukemia virus.

Authors:  G F Gerard; D P Grandgenett
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Properties of a P70 proteolytic factor of murine leukemia viruses.

Authors:  Y Yoshinaka; R B Luftig
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

View more
  21 in total

1.  Analysis of mutations in the integration function of Moloney murine leukemia virus: effects on DNA binding and cutting.

Authors:  M J Roth; P Schwartzberg; N Tanese; S P Goff
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

2.  Mutational analysis of the carboxyl terminus of the Moloney murine leukemia virus integration protein.

Authors:  M J Roth
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

3.  Transfer RNA genes are genomic targets for de Novo transposition of the yeast retrotransposon Ty3.

Authors:  D L Chalker; S B Sandmeyer
Journal:  Genetics       Date:  1990-12       Impact factor: 4.562

4.  A chimeric Ty3/Moloney murine leukemia virus integrase protein is active in vivo.

Authors:  S L Dildine; J Respess; D Jolly; S B Sandmeyer
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration.

Authors:  M Katzman; R A Katz; A M Skalka; J Leis
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

6.  Integrase mutants of human immunodeficiency virus type 1 with a specific defect in integration.

Authors:  B Taddeo; W A Haseltine; C M Farnet
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

7.  Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain.

Authors:  T Masuda; V Planelles; P Krogstad; I S Chen
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 integrase: effect on viral replication of mutations at highly conserved residues.

Authors:  P M Cannon; W Wilson; E Byles; S M Kingsman; A J Kingsman
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  Both substrate and target oligonucleotide sequences affect in vitro integration mediated by human immunodeficiency virus type 1 integrase protein produced in Saccharomyces cerevisiae.

Authors:  A D Leavitt; R B Rose; H E Varmus
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Genetic analysis of the human immunodeficiency virus type 1 integrase protein.

Authors:  C G Shin; B Taddeo; W A Haseltine; C M Farnet
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.